Jarol, Alkhalid P.
HRN: 18-60-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/10/2022
06/17/2022
IVT
401mg
Q6
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes